12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga·05/05/2025 17:05:51

Listen to the news

Gainers

NuCana (NASDAQ:NCNA) stock moved upwards by 52.8% to $0.7 during Monday's regular session. The company's market cap stands at $4.2 million.
Immutep (NASDAQ:IMMP) stock moved upwards by 35.6% to $2.32. The market value of their outstanding shares is at $337.2 million.
INVO Fertility (NASDAQ:IVF) stock moved upwards by 33.33% to $2.4. The company's market cap stands at $11.8 million.
Regencell Bioscience (NASDAQ:RGC) shares moved upwards by 31.91% to $80.8. The company's market cap stands at $1.0 billion.
Alterity Therapeutics (NASDAQ:ATHE) shares rose 23.54% to $4.25. The company's market cap stands at $62.9 million.
Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares increased by 23.2% to $0.31. The market value of their outstanding shares is at $4.3 million.

Losers

Integra Lifesciences (NASDAQ:IART) stock decreased by 26.4% to $12.4 during Monday's regular session. The company's market cap stands at $957.9 million. As per the news, the Q1 earnings report came out today.
Nexalin Technology (NASDAQ:NXL) shares decreased by 23.47% to $1.37. The market value of their outstanding shares is at $18.2 million.
Impact BioMedical (AMEX:IBO) shares declined by 22.46% to $0.58. The market value of their outstanding shares is at $6.6 million.
AirSculpt Technologies (NASDAQ:AIRS) stock fell 21.2% to $2.38. The market value of their outstanding shares is at $139.4 million. As per the press release, Q1 earnings came out yesterday.
ImmunityBio (NASDAQ:IBRX) stock declined by 19.49% to $2.04. The market value of their outstanding shares is at $1.8 billion.
PTC Therapeutics (NASDAQ:PTCT) stock declined by 17.48% to $41.22. The market value of their outstanding shares is at $3.2 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English